Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000950142-25-000189
Filing Date
2025-01-23
Accepted
2025-01-23 18:21:51
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es250582075_3a-may.html 3/A  
1 OWNERSHIP DOCUMENT es250582075_3a-may.xml 3/A 3353
  Complete submission text file 0000950142-25-000189.txt   4821
Mailing Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4
Business Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4 (732) 300-3046
Medicus Pharma Ltd. (Issuer) CIK: 0001997296 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 KING ST W SUITE 3400 TORONTO Z4 M5X 1A4
Business Address
May Sara R. (Reporting) CIK: 0002048946 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-42408 | Film No.: 25551222